GRAP2
GRB2-related adapter protein 2
Also known as: GADS, GRAP2_HUMAN, GRBLG, GrbX, Grf40, Mona
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75791
- Gene
- GRAP2
- Ensembl
- ENSG00000100351
- Chromosome
- 22
- Canonical length
- 330 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
OverviewNCBI Gene
This gene encodes a member of the GRB2/Sem5/Drk family. This member is an adaptor-like protein involved in leukocyte-specific protein-tyrosine kinase signaling. Like its related family member, GRB2-related adaptor protein (GRAP), this protein contains an SH2 domain flanked by two SH3 domains. This protein interacts with other proteins, such as GRB2-associated binding protein 1 (GAB1) and the SLP-76 leukocyte protein (LCP2), through its SH3 domains. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Apr 2014]
Canonical amino-acid sequenceUniProt
330 residues, UniProt reviewed canonical sequence.
>O75791|GRAP2
1 MEAVAKFDFT ASGEDELSFH TGDVLKILSN QEEWFKAELG SQEGYVPKNF IDIQFPKWFH
61 EGLSRHQAEN LLMGKEVGFF IIRASQSSPG DFSISVRHED DVQHFKVMRD NKGNYFLWTE
121 KFPSLNKLVD YYRTNSISRQ KQIFLRDRTR EDQGHRGNSL DRRSQGGPHL SGAVGEEIRP
181 SMNRKLSDHP PTLPLQQHQH QPQPPQYAPA PQQLQQPPQQ RYLQHHHFHQ ERRGGSLDIN
241 DGHCGTGLGS EMNAALMHRR HTDPVQLQAA GRVRWARALY DFEALEDDEL GFHSGEVVEV
301 LDSSNPSWWT GRLHNKLGLF PANYVAPMTRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRAP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 172 nTPM
Expression across tissuesHPA
Tissue
- thymus: 172 nTPM
- lymph node: 15 nTPM
- tonsil: 12 nTPM
- bone marrow: 9.7 nTPM
- spleen: 8.8 nTPM
- appendix: 7.5 nTPM
Single-cell type
- platelets: 1,720 nCPM
- mast cells: 347 nCPM
- t-cells: 217 nCPM
- megakaryocytes: 192 nCPM
- nk-cells: 76 nCPM
- thymocytes: 41 nCPM
Immune cell
- total PBMC: 75 nTPM
- naive CD8 T-cell: 58 nTPM
- memory CD8 T-cell: 56 nTPM
- gdT-cell: 52 nTPM
- MAIT T-cell: 38 nTPM
- memory CD4 T-cell: 38 nTPM
Brain region
- white matter: 1.4 nTPM
- choroid plexus: 1.2 nTPM
- medulla oblongata: 1.2 nTPM
- pons: 1 nTPM
- spinal cord: 1 nTPM
- thalamus: 0.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.77
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.12
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SH2 domain
- SH3 domain
- SH3-like domain superfamily
- SH2 domain superfamily
- Grb2-like
- SH2 domain
- SH3 domain
- GRAP2, C-terminal SH3 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GRAP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRAP2 as an antibody target. Whether an autoantibody or antibody against GRAP2 could matter depends on whether native GRAP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRAP2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GRAP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...